Zheng (Wilson) Wang, Associate Editor for Journal of Translational Medicine at Springer Nature and Associate Professor and Associate Consultant at Ruijin Hospital Affiliated to Shanghai Jiao Tong University, School of Medicine, shared a post on LinkedIn:
“I am happy to announce that our new research, titled ‘Development and validation of prognostic model based on distribution and density of CD3+ and CD8+ infiltrating lymphocytes in breast cancer: A multicenter cohort study’, has been published in The Breast.
Highlights of this research
- A scoring model named Prognosis Immunoindex (PII) was developed based on distribution and density of CD3+ and CD8+ infiltrating lymphocytes in breast cancer tissue.
- PII was an independent prognostic factor for DFS and OS in breast cancer patients.
- The prognostic value of PII has been validated in a large multicenter cohort.
- PII showed prominent prognostic value in HER2-positive and TNBC subtypes.”
Title: Development and validation of prognostic model based on distribution and density of CD3+ and CD8+ infiltrating lymphocytes in breast cancer: A multicenter cohort study
Authors: Xu Zhang, Zheng Wang, Yiwei Tong, Xi Sun, Weiqi Gao, Xiaocun Fei, Yujie Tang, Juanying Zhu, Zhi’an Li, Kunwei Shen, and Xiaosong Chen
You can read the Full Article in The Breast.
More posts featuring Zheng (Wilson) Wang.
